patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
stiripentol
Marketedupdated 2mo agoby Biocodex
Approvedcommunity read0 votes
all catalysts(8)
approval · 6
Aug 20, 2018
approval
DIACOMIT (STIRIPENTOL) — FDA approval
stiripentol
→
Aug 20, 2018
approval
DIACOMIT (STIRIPENTOL) — FDA approval
stiripentol
→
Jul 14, 2022
approval
DIACOMIT (STIRIPENTOL) — FDA approval
stiripentol
→
Jul 14, 2022
approval
DIACOMIT (STIRIPENTOL) — FDA approval
stiripentol
→
Apr 15, 2026
approval
DIACOMIT (STIRIPENTOL) — FDA approval
stiripentol
→
Apr 15, 2026
approval
DIACOMIT (STIRIPENTOL) — FDA approval
stiripentol
→
phase 1 completion · 2
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that